References
- Leysen J. E., Gommeren W., Laduron Spiperone P. M. a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding, Biochem. Pharmacol. 1978; 27: 307–316
- Leysen J. E. Receptors for neuroleptic drugs. Advances in Human Psychopharmacology, G. D. Burrows, J. S. Erry. JAI Press, Greenwich 1984; Vol. 3: 315–356
- Lewi P. J. Multivariate data analysis in industrial practice, J. Wiley. Research Studies Press, Chichester 1982
- Harman H. H. Modern factor analysis. University of Chicago, Chicago 1967
- Janssen P. A.J., Niemegeers C. J.E., Schellekens K. H.L. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part II. Neuroleptic activity spectra for dogs. Arzneim.-Forsch. 1965; 15: 1196–1206
- Leysen J. E., Gommeren W. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites. J. Neurochem. 1981; 36: 201–219
- Leysen J., Van Gompel P. Effects of proteolytic enzymes and monovalent ions demonstrate protease-sensitive and protease-insensitive stereospecific binding sites on dopaminergic receptors in rat striatum. Biochem. Pharmacol. 1982; 31: 1343–1355
- Leysen J. E. Multiple dopamine receptors: Relevance of in vitro binding data for subclassification of binding sites, in Catecholamines. Proceedings of the 5th International Catecholamine Symposium, E. Usdin, A. Dahlström, J. Engel. Alan R. Liss, New York 1984, in press
- Leysen J. E., Gommeren W. Different kinetic properties of neuroleptic receptor binding in the rat striatum and frontal cortex. Life Sci. 1978; 23: 447–452
- Gommeren W., Leysen J. E. Binding properties of 3H-lofentanil at the opiate receptor. Arch. Int. Pharmacodyn. Ther. 1982; 258: 171–173
- Janssen P. A.J., Niemegeers C. J.E., Schellekens K. H.L. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part I. Neuroleptic activity spectra for rats. Arzneim.-Forsch. 1965; 15: 104–117
- Niemegeers C. J.E., Heykants J. J.P., Janssen P. A.J. Antiemetic effect of haloperidol in the dog as related to plasma level and dose. Psychopharmacology 1981; 75: 240–244
- Migdaloff B. H., Grindel J. M., Heykants J. J.P., Janssen P. A.J. Penfluridol: A neuroleptic drug designed for long duration of action. Drug Metab. Rev. 1979; 9: 291–299
- Cressman W. A., Plostnieks J., Johnson P. C. Absorption, metabolism and excretion of droperidol by human subjects following intramuscular and intravenous administration. Anesthesiology 1973; 38: 363–369
- Authors. Long-term Effects of Neuroleptics, Advances in Biochemical Psychopharmacology, F. Cattabeni, G. Racagni, P. F. Spano, E. Costa. Raven Press, New York 1980; Vol. 24: 1–607